Source: Annual Congress 2004 - Complications and prognosis of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Saratov, Russia). Pulmonary hypertension at the patients with bronchial asthma and COPD. Eur Respir J 2004; 24: Suppl. 48, 483

Member's Comments

No comment yet.

Related content which might interest you: Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Systemic inflammation and pulmonary hypertension in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Pulmonary vascular remodelling in COPD versus bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Bronchial hyperreactivity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Pulmonary hypertension in eosinophilic versus noneosinophilic COPD Source: ERJ Open Res, 7 (1) 00772-2020; 10.1183/23120541.00772-2020 Year: 2021 Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 COPD and other pulmonary diseases Source: Eur Respir Monogr 2015; 67: 161-178 Year: 2015 Symptom of pulmonary arterial hypertension in patients-smokers and ex-smokers with COPD and in patients-smokers and non-smokers with bronchial asthma (BA) Source: Eur Respir J 2004; 24: Suppl. 48, 494s Year: 2004 Prevalence of bronchial asthma among pulmonary TB cases and impact of basic therapy of bronchial asthma on bronchial obstruction in pulmonary TB cases Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 546s Year: 2007 Bronchial hyperresponsiveness in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Bronchial vascularity in the airways of chronic bronchitis and COPD smokers Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010